Vinblastine VS. nitrogen mustard therapy of Hodgkin's disease
- 1 August 1968
- Vol. 22 (2), 473-479
- https://doi.org/10.1002/1097-0142(196808)22:2<473::aid-cncr2820220227>3.0.co;2-i
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Hodgkin's DiseaseAnnals of Internal Medicine, 1967
- High-Dose Corticoid Therapy in Hodgkin's Disease and other LymphomasAnnals of Internal Medicine, 1967
- Combined Vinblastine and Chlorambucil Therapy of Hodgkin's DiseaseAnnals of Internal Medicine, 1965
- Chlorambucil Therapy for Lymphomas and Chronic Lymphocytic LeukemiaJAMA, 1965
- METHYL-HYDRAZINE IN TREATMENT OF HODGKIN'S DISEASE AND VARIOUS FORMS OF HÆMATOSARCOMA AND LEUKÆMIAThe Lancet, 1963
- Clinical Experience with Vincaleukoblastine in Far-advanced Hodgkin's Disease and Various Malignant StatesAnnals of Internal Medicine, 1962
- SUMMARY OF RESULTS OBTAINED WITH NITROGEN MUSTARD IN THE TREATMENT OF NEOPLASTIC DISEASEAnnals of the New York Academy of Sciences, 1958
- A QUANTITATIVE EVALUATION OF THE CONTRIBUTION OF NITROGEN MUSTARD TO THE THERAPEUTIC MANAGEMENT OF HODGKIN'S DISEASEAnnals of Internal Medicine, 1951
- NITROGEN MUSTARD THERAPY IN HODGKIN’S DISEASEBlood, 1949
- Nitrogen-mustard therapy for hodgkin's disease, lymphosarcoma, the leuke-mias, and other disordersCancer, 1948